PP_1170x120_10-25-21

Tetrabenazine Tablets

Lupin launches generic tetrabenazine tablets

Lupin launches generic tetrabenazine tablets

MUMBAI and BALTIMORE, Md. — Pharma major Lupin announced the launch of tetrabenazine tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Tetrabenazine Tablets, 12.5 mg and 25 mg are the generic equivalent of Valeant Pharmaceuticals North America, LLC’s Xenazine tablets. It is

Lupin gets FDA approval for generic Xenazine tablets

Lupin gets FDA approval for generic Xenazine tablets

MUMBAI, BALTIMORE — Lupin announced today that it has received final approval for its Tetrabenazine tablets, 12.5 mg and 25 mg from the United States Food and Drug Administration (FDA) to market a generic version of Valeant Pharmaceuticals North America’s  Xenazine tablets, 12.5 mg and 25 mg. These are used for the treatment of chorea associated

Adheris Health